Literature DB >> 9153159

The search for disease-modifying treatment for Alzheimer's disease.

P S Aisen1, K L Davis.   

Abstract

As a result of advances in the understanding of neurodegenerative mechanism in Alzheimer's disease, several strategies for the development of disease-modifying treatment are being investigated. Nerve growth factor and other neurotrophins may improve neuronal survival, although targeted delivery remains an obstacle. Modulation of protein processing has the potential to decrease the formation of plaques and tangles. Pharmacologic reduction of oxidative stress and destructive inflammation may slow the rate of neurodegeneration. Continued research into basic mechanisms, along with therapeutic trials of promising drugs, are improving the likelihood that it will soon be possible to slow the progression of this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153159     DOI: 10.1212/wnl.48.5_suppl_6.35s

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

Review 1.  Diagnosis and management of dementia in primary care at an early stage: the need for a new concept and an adapted procedure.

Authors:  J De Lepeleire; J Heyrman
Journal:  Theor Med Bioeth       Date:  1999-06

Review 2.  Alzheimer's disease: current knowledge, management and research.

Authors:  S Gauthier; M Panisset; J Nalbantoglu; J Poirier
Journal:  CMAJ       Date:  1997-10-15       Impact factor: 8.262

Review 3.  Advances and challenges in the prevention and treatment of Alzheimer's disease.

Authors:  R Diaz Brinton; R S Yamazaki
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

Review 4.  Causes of Alzheimer's disease.

Authors:  D G Munoz; H Feldman
Journal:  CMAJ       Date:  2000-01-11       Impact factor: 8.262

5.  Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease.

Authors:  Daniela L Krause; Norbert Müller
Journal:  Int J Alzheimers Dis       Date:  2010-06-14

6.  A preliminary investigation of anticholinesterase activity of some Iranian medicinal plants commonly used in traditional medicine.

Authors:  Seyed Behzad Jazayeri; Arash Amanlou; Naghmeh Ghanadian; Parvin Pasalar; Massoud Amanlou
Journal:  Daru       Date:  2014-01-08       Impact factor: 3.117

Review 7.  The Quest for an Alzheimer Therapy.

Authors:  Stefano F Cappa
Journal:  Front Neurol       Date:  2018-03-01       Impact factor: 4.003

8.  In vitro antioxidant and cholinesterase inhibitory activities of methanolic fruit extract of Phyllanthus acidus.

Authors:  Md Moniruzzaman; Md Asaduzzaman; Md Sarwar Hossain; Jyotirmoy Sarker; S M Abdur Rahman; Mamunur Rashid; Md Mosiqur Rahman
Journal:  BMC Complement Altern Med       Date:  2015-11-09       Impact factor: 3.659

9.  Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L.

Authors:  Muhammad Ayaz; Muhammad Junaid; Jawad Ahmed; Farhat Ullah; Abdul Sadiq; Sajjad Ahmad; Muhammad Imran
Journal:  BMC Complement Altern Med       Date:  2014-05-03       Impact factor: 3.659

10.  New anthrarobin acyl derivatives as butyrylcholinesterase inhibitors: synthesis, in vitro and in silico studies.

Authors:  Mehreen Lateef; Abid Azhar; Bina S Siddiqui; Shamshad Zarina; Nizam Uddin; Muhammad F Anwar; Kauser Siddiqui; Kaniz F Azhar; Lubna Iqbal; Rashad Mehmood; Shagufta Perveen
Journal:  Heliyon       Date:  2017-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.